Oxidative stress in Alzheimer disease: A possibility for prevention

Oxidative stress is at the forefront of Alzheimer disease (AD) research. While its implications in the characteristic neurodegeneration of AD are vast, the most important aspect is that it seems increasingly apparent that oxidative stress is in fact a primary progenitor of the disease, and not merel...

Full description

Saved in:
Bibliographic Details
Published inNeuropharmacology Vol. 59; no. 4; pp. 290 - 294
Main Authors Bonda, David J., Wang, Xinglong, Perry, George, Nunomura, Akihiko, Tabaton, Massimo, Zhu, Xiongwei, Smith, Mark A.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.09.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Oxidative stress is at the forefront of Alzheimer disease (AD) research. While its implications in the characteristic neurodegeneration of AD are vast, the most important aspect is that it seems increasingly apparent that oxidative stress is in fact a primary progenitor of the disease, and not merely an epiphenomenon. Moreover, evidence indicates that a long “dormant period” of gradual oxidative damage accumulation precedes and actually leads to the seemingly sudden appearance of clinical and pathological AD symptoms, including amyloid-β deposition, neurofibrillary tangle formation, metabolic dysfunction, and cognitive decline. These findings provide important insights into the development of potential treatment regimens and even allude to the possibility of a preventative cure. In this review, we elaborate on the dynamic role of oxidative stress in AD and present corresponding treatment strategies that are currently under investigation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0028-3908
1873-7064
1873-7064
DOI:10.1016/j.neuropharm.2010.04.005